Search

Displaying results 6901 - 6910 of 10000 in total
  1. Drug

    Freselestat

    go.drugbank.com/drugs/DB03925
    Experimental

  2. Drug

    TRU-015

    go.drugbank.com/drugs/DB05580
    Investigational

  3. Drug

    CRD5

    go.drugbank.com/drugs/DB05587
    Experimental

  4. Drug

    Emfilermin

    go.drugbank.com/drugs/DB06562
    Investigational

  5. Drug

    Fibroblast growth factor-1

    go.drugbank.com/drugs/DB05599
    Investigational

  6. Drug

    CTCE-9908

    go.drugbank.com/drugs/DB05625
    Investigational

  7. Drug

    Ertumaxomab

    go.drugbank.com/drugs/DB18923
    Investigational

    Ertumaxomab is under investigation in clinical trial NCT00522457 (Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy).

  8. Drug

    Ceralasertib

    go.drugbank.com/drugs/DB14917
    Investigational

    Ceralasertib is under investigation in clinical trial NCT03682289 (Phase II Trial of AZD6738 Alone and in Combination With Olaparib).

  9. Drug

    Hexoprenaline

    go.drugbank.com/drugs/DB08957
    ApprovedWithdrawn

    Hexoprenaline is a stimulant of beta 2 adrenergic receptors. It is used as a bronchodilator, antiasthmatic, and tocolytic agent.

  10. Drug

    Fenticonazole

    go.drugbank.com/drugs/DB13434
    Investigational

    Fenticonazole has a broad spectrum of antimycotic activity against dermatophytes and yeasts.